BlackRock Advisors’s Flexion Therapeutics, Inc. FLXN Stock Holding History

BlackRock Advisors’s Portfolio FLXN Stock Details FLXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$262K	Sell	13,762 -16,851	-55%	-$322K	﹤0.01%	2572
2016 Q3	$598K	Buy	30,613 +3,887	+15%	+$65.7K	﹤0.01%	2091
2016 Q2	$400K	Sell	26,726 -17,841	-40%	-$224K	﹤0.01%	2239
2016 Q1	$410K	Buy	44,567 +23,549	+112%	+$286K	﹤0.01%	2186
2015 Q4	$405K	Sell	21,018 -4,103	-16%	-$71.2K	﹤0.01%	2202
2015 Q3	$373K	Buy	25,121 +17,082	+212%	+$401K	﹤0.01%	2392
2015 Q2	$176K	Buy	8,039 +5,094	+173%	+$103K	﹤0.01%	2865
2015 Q1	$66K	Buy	2,945 +776	+36%	+$18K	﹤0.01%	3182
2014 Q4	$44K	Buy	2,169 +265	+14%	+$4.8K	﹤0.01%	3304
2014 Q3	$35K	Hold	1,904	–	–	﹤0.01%	3359
2014 Q2	$26K	Buy	1,904 +862	+83%	+$11.8K	﹤0.01%	3387
2014 Q1	$17K	Buy	+1,042	New	+$18K	﹤0.01%	3451

Other funds holding FLXN

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

PCM

Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

BlackRock Advisors's FLXN Position: Q4 2016 in Review

BlackRock Advisors reduced its Flexion Therapeutics, Inc. (FLXN) stake by 55% in Q4 2016, selling an estimated $322K and leaving 13,762 shares worth $262K. The position accounts for ﹤0.01% of the portfolio, ranked #2572.

BlackRock Advisors first reported a position in FLXN in Q1 2014 and has held it in 12 quarters since. The position peaked at $598K in Q3 2016. 94 funds tracked by Wall St. Rank hold FLXN as of Q4 2016.

BlackRock Advisors held 13,762 shares of Flexion Therapeutics, Inc. worth $262K as of Q4 2016.
BlackRock Advisors sold 16,851 Flexion Therapeutics, Inc. shares in Q4 2016, an estimated $322K.
Flexion Therapeutics, Inc. made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #2572 holding.
BlackRock Advisors first reported a position in Flexion Therapeutics, Inc. in Q1 2014 and has held it in 12 quarters since.
BlackRock Advisors's Flexion Therapeutics, Inc. position peaked at $598K in Q3 2016.
94 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.